Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
HEPA

Updated 10/6/2026, 9:41 AM ET.

HEPA

Hepion Pharmaceuticals, Inc.

Buy$10,000

Fisher Danina

Director

200,000 shat $0.05Filed Oct 2, 4:30 PM ETFiling
HEPA

Hepion Pharmaceuticals, Inc.

Buy$25,000

Stetz Gary S. II

Director

500,000 shat $0.05Filed Aug 12, 9:43 PM ETFiling
HEPA

Hepion Pharmaceuticals, Inc.

Buy$100,000

Stetz Gary S.

Interim CEO, Director

2,000,000 shat $0.05Filed Aug 12, 9:41 PM ETFiling
HEPA

Hepion Pharmaceuticals, Inc.

Buy$100,000

Purcell Michael J.

Director

2,000,000 shat $0.05Filed Aug 12, 9:39 PM ETFiling
HEPA

Hepion Pharmaceuticals, Inc.

Buy$100,000

Appajosyula Sireesh

Chief Operating Officer, Director

2,000,000 shat $0.05Filed Aug 12, 9:36 PM ETFiling
HEPA

Hepion Pharmaceuticals, Inc.

Buy$500,000

LoPriore Vincent S

Executive Chairman, Director

10,000,000 shat $0.05Filed Aug 12, 9:34 PM ETFiling

Read from public SEC filings. Not financial advice.